“Novozymes works with innovative customers across the globe to help them produce more from less, make their products stand out and reduce costs,” says Claus Crone Fuglsang, CSO and Senior Vice President, Research & Technology, Novozymes. “Benson Hill’s robust portfolio of gene editing nucleases and collaborative approach to empowering innovation aligns with our mission to leverage biological innovations and create new opportunities for our customers.” Read more from Seed Today here.